0000021665False00000216652025-01-312025-01-310000021665us-gaap:CommonStockMember2025-01-312025-01-310000021665cl:A0.500NotesDue2026Member2025-01-312025-01-310000021665cl:A0300NotesDue2029Member2025-01-312025-01-310000021665cl:A1.375NotesDue2034Member2025-01-312025-01-310000021665cl:A0.875Notesdue2039Member2025-01-312025-01-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 31, 2025
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
| | | | | | | | |
Delaware | 1-644 | 13-1815595 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| | | | | | | | | | | | | | |
300 Park Avenue, | New York, | NY | | 10022 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Securities 12(b) of the Act:
| | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange
on which registered |
Common Stock, $1.00 par value | CL | New York Stock Exchange |
0.500% Notes due 2026 | CL26 | New York Stock Exchange |
0.300% Notes due 2029 | CL29 | New York Stock Exchange |
1.375% Notes due 2034 | CL34 | New York Stock Exchange |
0.875% Notes due 2039 | CL39 | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On January 31, 2025, Colgate-Palmolive Company (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2024. This press release is attached as Exhibit 99 and is incorporated herein by reference.
The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
| | | | | |
Exhibit Number | Description |
| |
| 99 | Press release, dated January 31, 2025, issued by Colgate-Palmolive Company |
| |
| 104 | Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document) |
EXHIBIT INDEX
| | | | | |
Exhibit Number | Description |
| |
| |
| |
| 104 | Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
| | | | | | | | | | | |
| | COLGATE-PALMOLIVE COMPANY | |
| | | |
Date: January 31, 2025 | | By: /s/ Stanley J. Sutula III | |
| | Name: Stanley J. Sutula III | |
| | Title: Chief Financial Officer | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Exhibit 99
Colgate Announces 4th Quarter and Full Year 2024 Results
Full Year
•Delivered over $20 billion in Net sales for the first time
•Net sales increased 3.3%; Organic sales* increased 7.4%, including a 0.5% negative impact from lower private label pet volume
•GAAP EPS increased 27% to $3.51; Base Business EPS* increased 11% to $3.60
•Net cash provided by operations was $4,107 for the full year, up 10% versus 2023
•Returned $3.4 billion in cash to shareholders through dividends and share repurchases
| | | | | | | | | | | |
| Full Year Total Company Results (GAAP) |
| ($ in millions except per share amounts) | 2024 | 2023 | Change |
| Net Sales | $20,101 | $19,457 | +3.3 | % |
| EPS (diluted) | $3.51 | $2.77 | +27 | % |
| | | |
| | | |
| Full Year Total Company Results (Base Business - Non-GAAP)* |
| ($ in millions except per share amounts) | 2024 | 2023 | Change |
| Organic Sales Growth | +7.4 | % |
| Base Business EPS (diluted) | $3.60 | $3.23 | +11 | % |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 7 - Geographic Sales Analysis Percentage Changes” and “Table 9 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
Fourth Quarter
•Net sales decreased 0.1%; Organic sales* increased 4.3%, including a 0.5% negative impact from lower private label pet volume
•GAAP EPS increased 3% to $0.90; Base Business EPS* increased 5% to $0.91
•GAAP Gross profit margin and Base Business Gross profit margin* both increased 70 basis points to 60.3%
•Colgate’s leadership in toothpaste continued with its global market share at 41.4% year to date
•Colgate’s leadership in manual toothbrushes continued with its global market share at 32.2% year to date
| | | | | | | | | | | |
| Fourth Quarter Total Company Results (GAAP) |
| ($ in millions except per share amounts) | 2024 | 2023 | Change |
| Net Sales | $4,944 | $4,950 | -0.1 | % |
| EPS (diluted) | $0.90 | $0.87 | +3 | % |
| | | |
| | | |
| Fourth Quarter Total Company Results (Base Business - Non-GAAP)* |
| ($ in millions except per share amounts) | 2024 | 2023 | Change |
| Organic Sales Growth | +4.3 | % |
| Base Business EPS (diluted) | $0.91 | $0.87 | +5 | % |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
New York, New York, January 31, 2025…Colgate-Palmolive Company (NYSE:CL) today reported results for fourth quarter and full year 2024. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business fourth quarter and full year results, “We are pleased to have delivered another quarter and full year of strong organic sales growth along with increases in gross profit, gross profit margin, net income, earnings per share and cash flow. Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds. We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025.
“For the full year, we grew net sales 3.3% and organic sales 7.4%, with organic sales growth in every division and in all four of our categories. This was our sixth consecutive year with organic sales growth at or above our 3% to 5% targeted range. The combination of strong sales growth and operating leverage drove strong bottom-line performance as well, with net income and earnings per share both increasing double digits versus 2023.
“Our strong margin performance allowed us to continue to invest to drive brand health and support innovation with a 15% increase in advertising spending in 2024, following a 19% increase in 2023. We have built flexibility into our income statement so we can continue to invest in scaling our capabilities in key areas like digital and data and analytics across the organization to accelerate change and build competitive advantages, while delivering bottom-line growth.
“Reaching $20 billion in net sales for the year is an exciting milestone and I’d like to thank all Colgate people globally for their hard work and dedication to achieving our goals together. The quality of our results this year and our strong growth momentum add to our confidence that we are well positioned to deliver consistent, compounded earnings per share growth in 2025 and beyond.”
Full Year 2025 Guidance
Based on current spot rates:
•The Company expects net sales to be roughly flat, including a mid-single-digit negative impact from foreign exchange.
•The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%, including the impact of the planned exit from private label pet nutrition over the course of 2025.
•On a GAAP basis, the Company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and mid-single-digit earnings-per-share growth.
•On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and low to mid-single-digit earnings-per-share growth.
Divisional Performance
The following are comments about divisional performance for fourth quarter 2024 versus the year ago period. See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.
| | | | | | | | | | | | | | | | | | | | | |
Fourth Quarter Sales Growth By Division (% change 4Q 2024 vs. 4Q 2023) | | | |
| % of Total Company Sales | Net
Sales | Organic
Sales* |
Volume | | Pricing | FX |
North America(1) | 21.0% | -1.0% | -0.7% | +1.9% | | -2.7% | -0.3% |
| Latin America | 22.4% | -7.2% | +9.2% | +0.9% | | +8.3% | -16.4% |
Europe(1) | 13.5% | +4.9% | +4.5% | +1.7% | | +2.7% | +0.4% |
| Asia Pacific | 14.6% | +3.7% | +3.8% | +5.8% | | -2.0% | —% |
| Africa/Eurasia | 5.4% | +2.8% | +9.4% | +11.5% | | -2.1% | -6.6% |
| Hill's | 23.1% | +2.3% | +2.9% | +0.8% | | +2.0% | -0.5% |
| | | | | | | | |
| Total Company | 100.0% | -0.1% | +4.3% | +2.5% | | +1.8% | -4.4% |
Note: Table may not sum due to rounding.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024. The results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment. Recast historical geographic segment information can be found on the Company's website.
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
| | | | | | | | | | | | | | |
Fourth Quarter Operating Profit By Division ($ in millions) | |
| 4Q 2024 | % Change vs 4Q 2023 | % to Net Sales | Change in basis points vs 4Q 2023
% to Net Sales |
North America(1) | $206 | -11% | 19.9% | -220 |
| Latin America | $339 | -8% | 30.6% | -10 |
Europe(1) | $155 | 3% | 23.3% | -40 |
| Asia Pacific | $211 | 4% | 29.1% | +10 |
| Africa/Eurasia | $58 | -1% | 21.5% | -80 |
| Hill's | $275 | 19% | 24.1% | +340 |
| | | | | |
| Total Company, As Reported | $1,064 | -1% | 21.5% | -20 |
| Total Company, Base Business* | $1,071 | —% | 21.7% | — |
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
Prepared Materials and Webcast Information
At approximately 7:00 a.m. ET today, Colgate will post its prepared materials (in PDF format)
regarding fourth quarter and full year 2024 results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.
At 8:30 a.m. ET today, Colgate will host a conference call regarding fourth quarter and full year 2024 results. To access this call as a webcast, please go to Colgate’s website at www.colgatepalmolive.com.
About Colgate-Palmolive
Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate’s global business and how the Company is building a future to smile about, visit www.colgatepalmolive.com. CL-E
The Company's annual meeting of stockholders is currently scheduled for Friday, May 9, 2025.
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange,
the impact of any additional tariffs, the impact of the war in Ukraine, the conflict in the Middle East and tensions between China and Taiwan, cost-reduction plans, tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.
Non-GAAP Financial Measures
The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:
•Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to an ERISA litigation matter, a foreign tax matter, the 2022 Global Productivity Initiative and product recall costs.
•Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
•Free cash flow before dividends: Net cash provided by operations less Capital expenditures.
This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and twelve months ended December 31, 2024 versus 2023 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.
Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters,
acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and twelve months ended December 31, 2024 and 2023 included with this release for a reconciliation of these financial measures to the related GAAP measures.
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the twelve months ended December 31, 2024 and 2023 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.
(See attached tables for fourth quarter and full year results.)
Contacts
Investor Relations: investor_relations@colpal.com
Communications: colgate_palmolive_media_inquiry@colpal.com
| | | | | | | | | | | | | | |
| | | | Table 1 |
| Colgate-Palmolive Company |
|
| Condensed Consolidated Statements of Income |
|
| For the Three Months Ended December 31, 2024 and 2023 |
|
| (Dollars in Millions Except Per Share Amounts) (Unaudited) |
|
| | 2024 | | 2023 |
| | | | |
| Net sales | | $ | 4,944 | | | $ | 4,950 | |
| | | | |
| Cost of sales | | 1,962 | | | 2,000 | |
| | | | |
| Gross profit | | 2,982 | | | 2,950 | |
| | | | |
| Gross profit margin | | 60.3 | % | | 59.6 | % |
| | | | |
| Selling, general and administrative expenses | | 1,895 | | | 1,803 | |
| | | | |
| Other (income) expense, net | | 23 | | | 75 | |
| | | | |
| | | | |
| | | | |
| Operating profit | | 1,064 | | | 1,072 | |
| | | | |
| Operating profit margin | | 21.5 | % | | 21.7 | % |
| | | | |
| Non-service related postretirement costs | | 20 | | | 22 | |
| | | | |
| Interest expense | | 66 | | | 74 | |
| | | | |
| Interest income | | 16 | | | 12 | |
| | | | |
| Income before income taxes | | 994 | | | 988 | |
| | | | |
| Provision for income taxes | | 215 | | | 228 | |
| | | | |
| Effective tax rate | | 21.6 | % | | 23.1 | % |
| | | | |
| Net income including noncontrolling interests | | 779 | | | 760 | |
| | | | |
| Less: Net income attributable to noncontrolling interests | | 40 | | | 42 | |
| | | | |
| Net income attributable to Colgate-Palmolive Company | | $ | 739 | | | $ | 718 | |
| | | | |
| Earnings per common share | | | | |
| Basic | | $ | 0.91 | | | $ | 0.87 | |
| Diluted | | $ | 0.90 | | | $ | 0.87 | |
| | | | |
| Supplemental Income Statement Information | | | | |
| Average common shares outstanding | | | | |
| Basic | | 816.0 | | | 823.4 | |
| Diluted | | 819.7 | | | 825.1 | |
| | | | |
| Advertising | | $ | 648 | | | $ | 593 | |
| | | | |
| | | | |
| | | | |
| | | | |
|
|
|
|
| | | | | | | | | | | | | | |
| | | | Table 2 |
| Colgate-Palmolive Company |
|
| Condensed Consolidated Statements of Income |
|
| For the Twelve Months Ended December 31, 2024 and 2023 |
|
| (Dollars in Millions Except Per Share Amounts) (Unaudited) |
|
| | 2024 | | 2023 |
| | | | |
| Net sales | | $ | 20,101 | | | $ | 19,457 | |
| | | | |
| Cost of sales | | 7,940 | | | 8,131 | |
| | | | |
| Gross profit | | 12,161 | | | 11,326 | |
| | | | |
| Gross profit margin | | 60.5 | % | | 58.2 | % |
| | | | |
| Selling, general and administrative expenses | | 7,729 | | | 7,151 | |
| | | | |
| Other (income) expense, net | | 164 | | | 191 | |
| | | | |
| | | | |
| | | | |
| Operating profit | | 4,268 | | | 3,984 | |
| | | | |
| Operating profit margin | | 21.2 | % | | 20.5 | % |
| | | | |
| Non-service related postretirement costs | | 87 | | | 360 | |
| | | | |
| Interest expense | | 292 | | | 287 | |
| | | | |
| Interest income | | 67 | | | 55 | |
| | | | |
| Income before income taxes | | 3,956 | | | 3,392 | |
| | | | |
| Provision for income taxes | | 907 | | | 937 | |
| | | | |
| Effective tax rate | | 22.9 | % | | 27.6 | % |
| | | | |
| Net income including noncontrolling interests | | 3,049 | | | 2,455 | |
| | | | |
| Less: Net income attributable to noncontrolling interests | | 160 | | | 155 | |
| | | | |
| Net income attributable to Colgate-Palmolive Company | | $ | 2,889 | | | $ | 2,300 | |
| | | | |
| Earnings per common share | | | | |
Basic(1) | | $ | 3.53 | | | $ | 2.78 | |
Diluted(1) | | $ | 3.51 | | | $ | 2.77 | |
| | | | |
| Supplemental Income Statement Information | | | | |
| Average common shares outstanding | | | | |
| Basic | | 819.1 | | | 827.4 | |
| Diluted | | 823.2 | | | 829.2 | |
| | | | |
| Advertising | | $ | 2,720 | | | $ | 2,371 | |
| | | | |
Note:
(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period. |
|
|
| | | | | | | | | | | | | | |
| | | | Table 3 |
| Colgate-Palmolive Company |
|
| Condensed Consolidated Balance Sheets |
|
| As of December 31, 2024 and December 31, 2023 |
|
| (Dollars in Millions) (Unaudited) |
| | | | |
| | | | |
| | 2024 | | 2023 |
| Cash and cash equivalents | | $ | 1,096 | | | $ | 966 | |
| Receivables, net | | 1,521 | | | 1,586 | |
| Inventories | | 1,987 | | | 1,934 | |
| Other current assets | | 713 | | | 793 | |
| Property, plant and equipment, net | | 4,422 | | | 4,582 | |
| Goodwill | | 3,272 | | | 3,410 | |
| Other intangible assets, net | | 1,756 | | | 1,887 | |
| | | | |
| Other assets | | 1,279 | | | 1,235 | |
| Total assets | | $ | 16,046 | | | $ | 16,393 | |
| | | | |
| Total debt | | 7,949 | | | 8,549 | |
| Other current liabilities | | 5,099 | | | 4,411 | |
| Other non-current liabilities | | 2,454 | | | 2,476 | |
| Total liabilities | | 15,502 | | | 15,436 | |
| Total Colgate-Palmolive Company shareholders’ equity | | 212 | | | 609 | |
| Noncontrolling interests | | 332 | | | 348 | |
| Total liabilities and equity | | $ | 16,046 | | | $ | 16,393 | |
| | | | |
| Supplemental Balance Sheet Information | | | | |
Debt less cash, cash equivalents and marketable securities(1) | | $ | 6,693 | | | $ | 7,404 | |
| Working capital % of sales | | (5.2) | % | | (1.4) | % |
Note:
(1) Marketable securities of $160 and $179 as of December 31, 2024 and 2023, respectively, are included in Other current assets.
| | | | | | | | | | | | | | |
| | | | Table 4 |
| Colgate-Palmolive Company |
|
| Condensed Consolidated Statements of Cash Flows |
|
| For the Twelve Months Ended December 31, 2024 and 2023 |
|
| (Dollars in Millions) (Unaudited) |
| | | | |
| | 2024 | | 2023 |
| Operating Activities | | | | |
| Net income including noncontrolling interests | | $ | 3,049 | | | $ | 2,455 | |
| Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations: | | | | |
| Depreciation and amortization | | 605 | | | 567 | |
| ERISA litigation matter | | — | | | 267 | |
| Restructuring and termination benefits, net of cash | | 51 | | | (23) | |
| Stock-based compensation expense | | 135 | | | 122 | |
| | | | |
| | | | |
| | | | |
| | | | |
| Deferred income taxes | | (77) | | | (98) | |
| | | | |
| Cash effects of changes in: | | | | |
| Receivables | | (56) | | | (37) | |
| Inventories | | (100) | | | 194 | |
| Accounts payable and other accruals | | 516 | | | 309 | |
| Other non-current assets and liabilities | | (16) | | | (11) | |
| Net cash provided by operations | | 4,107 | | | 3,745 | |
| | | | |
| Investing Activities | | | | |
| Capital expenditures | | (561) | | | (705) | |
| Purchases of marketable securities and investments | | (574) | | | (506) | |
| Proceeds from sale of marketable securities and investments | | 564 | | | 502 | |
| | | | |
| | | | |
| Other investing activities | | 37 | | | (33) | |
| Net cash used in investing activities | | (534) | | | (742) | |
| | | | |
| Financing Activities | | | | |
| Short-term borrowing (repayment) less than 90 days, net | | 93 | | | (906) | |
| Principal payments on debt | | (503) | | | (903) | |
| Proceeds from issuance of debt | | 2 | | | 1,495 | |
| Dividends paid | | (1,789) | | | (1,749) | |
| Purchases of treasury shares | | (1,739) | | | (1,128) | |
| Proceeds from exercise of stock options | | 638 | | | 380 | |
| | | | |
| Other financing activities | | (91) | | | 18 | |
| Net cash used in financing activities | | (3,389) | | | (2,793) | |
| | | | |
| Effect of exchange rate changes on Cash and cash equivalents | | (54) | | | (19) | |
| Net increase (decrease) in Cash and cash equivalents | | 130 | | | 191 | |
| Cash and cash equivalents at beginning of the period | | 966 | | | 775 | |
| Cash and cash equivalents at end of the period | | $ | 1,096 | | | $ | 966 | |
| | | | |
| | | | |
| Supplemental Cash Flow Information | | | | |
| Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | | | | |
| Net cash provided by operations | | 4,107 | | | 3,745 | |
| Less: Capital expenditures | | (561) | | | (705) | |
| Free cash flow before dividends | | $ | 3,546 | | | $ | 3,040 | |
| | | | |
| Income taxes paid | | $ | 933 | | | $ | 937 | |
| Interest paid | | $ | 302 | | | $ | 280 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | Table 5 |
| Colgate-Palmolive Company |
| | | | |
| Segment Information |
| | | | |
| For the Three and Twelve Months Ended December 31, 2024 and 2023 |
| | | | |
| (Dollars in Millions) (Unaudited) |
| | | | | | |
| | Three Months Ended December 31, | | Twelve Months Ended December 31, |
| | 2024 | | 2023 | | 2024 | | 2023 |
| Net Sales | | | | | | | | |
| Oral, Personal and Home Care | | | | | | | | |
| | | | | | | | |
North America(1) | | $ | 1,036 | | | $ | 1,047 | | | $ | 4,113 | | | $ | 4,091 | |
| Latin America | | 1,106 | | | 1,192 | | | 4,782 | | | 4,640 | |
Europe(1) | | 668 | | | 637 | | | 2,770 | | | 2,571 | |
| Asia Pacific | | 724 | | | 698 | | | 2,858 | | | 2,782 | |
| Africa/Eurasia | | 269 | | | 262 | | | 1,095 | | | 1,083 | |
| | | | | | | | |
| Total Oral, Personal and Home Care | | 3,804 | | | 3,836 | | | 15,618 | | | 15,167 | |
| | | | | | | | |
| Pet Nutrition | | 1,140 | | | 1,114 | | | 4,483 | | | 4,290 | |
| | | | | | | | |
| Total Net Sales | | $ | 4,944 | | | $ | 4,950 | | | $ | 20,101 | | | $ | 19,457 | |
| | | | | | | | |
| | | | | | | | |
| | Three Months Ended December 31, | | Twelve Months Ended December 31, |
| | 2024 | | 2023 | | 2024 | | 2023 |
| Operating Profit | | | | | | | | |
| Oral, Personal and Home Care | | | | | | | | |
| | | | | | | | |
North America(1) | | $ | 206 | | | $ | 231 | | | $ | 839 | | | $ | 871 | |
| Latin America | | 339 | | | 366 | | | 1,526 | | | 1,417 | |
Europe(1) | | 155 | | | 151 | | | 658 | | | 573 | |
| Asia Pacific | | 211 | | | 203 | | | 812 | | | 767 | |
| Africa/Eurasia | | 58 | | | 59 | | | 253 | | | 254 | |
| | | | | | | | |
| Total Oral, Personal and Home Care | | 969 | | | 1,010 | | | 4,088 | | | 3,882 | |
| | | | | | | | |
| Pet Nutrition | | 275 | | | 231 | | | 965 | | | 806 | |
Corporate(2) | | (179) | | | (169) | | | (784) | | | (704) | |
| | | | | | | | |
| Total Operating Profit | | $ | 1,064 | | | $ | 1,072 | | | $ | 4,268 | | | $ | 3,984 | |
Notes: Tables may not sum due to rounding.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.
(2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three months ended December 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $7.
Corporate Operating profit (loss) for the three months ended December 31, 2023 included charges resulting from the 2022 Global Productivity Initiative of $2.
Corporate Operating profit (loss) for the twelve months ended December 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $85.
Corporate Operating profit (loss) for the twelve months ended December 31, 2023 included charges resulting from the 2022 Global Productivity Initiative of $27 and product recall costs of $25.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Table 6 |
| Colgate-Palmolive Company |
|
| Geographic Sales Analysis Percentage Changes |
|
| For the Three Months Ended December 31, 2024 vs. 2023 |
|
| (Unaudited) |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | COMPONENTS OF SALES CHANGE |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | Pricing | | |
| | | | | | | | | | | | Coupons | | |
| | Sales | | | | | | | | | | Consumer & | | |
| | Change | | Organic | | | | | | | | Trade | | Foreign |
| Region | | As Reported | | Sales Change | | Volume | | | | | | Incentives | | Exchange |
| | | | | | | | | | | | | | |
| Total Company | | (0.1)% | | 4.3% | | 2.5% | | | | | | 1.8% | | (4.4)% |
| | | | | | | | | | | | | | |
North America(1) | | (1.0)% | | (0.7)% | | 1.9% | | | | | | (2.7)% | | (0.3)% |
| | | | | | | | | | | | | | |
| Latin America | | (7.2)% | | 9.2% | | 0.9% | | | | | | 8.3% | | (16.4)% |
| | | | | | | | | | | | | | |
Europe(1) | | 4.9% | | 4.5% | | 1.7% | | | | | | 2.7% | | 0.4% |
| | | | | | | | | | | | | | |
| Asia Pacific | | 3.7% | | 3.8% | | 5.8% | | | | | | (2.0)% | | —% |
| | | | | | | | | | | | | | |
| Africa/Eurasia | | 2.8% | | 9.4% | | 11.5% | | | | | | (2.1)% | | (6.6)% |
| | | | | | | | | | | | | | |
| Total CP Products | | (0.8)% | | 4.7% | | 2.9% | | | | | | 1.8% | | (5.5)% |
| | | | | | | | | | | | | | |
| Hill’s | | 2.3% | | 2.9% | | 0.8% | | | | | | 2.0% | | (0.5)% |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Emerging Markets(2) | | (2.2)% | | 7.5% | | 3.7% | | | | | | 3.8% | | (9.7)% |
| | | | | | | | | | | | | | |
| Developed Markets | | 1.6% | | 1.7% | | 1.5% | | | | | | 0.3% | | (0.2)% |
Notes: Table may not sum due to rounding.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.
(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Table 7 |
| Colgate-Palmolive Company |
|
| Geographic Sales Analysis Percentage Changes |
|
| For the Twelve Months Ended December 31, 2024 vs. 2023 |
|
| (Unaudited) |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | COMPONENTS OF SALES CHANGE |
| | | | | | | | | | | | |
| | | | | | | | | | Pricing | | |
| | | | | | | | | | Coupons | | |
| | Sales | | | | | | | | Consumer & | | |
| | Change | | Organic | | | | | | Trade | | Foreign |
| Region | | As Reported | | Sales Change | | Volume | | | | Incentives | | Exchange |
| | | | | | | | | | | | |
| Total Company | | 3.3% | | 7.4% | | 3.1% | | | | 4.4% | | (4.1)% |
| | | | | | | | | | | | |
North America(1) | | 0.5% | | 0.7% | | 2.6% | | | | (1.9)% | | (0.1)% |
| | | | | | | | | | | | |
| Latin America | | 3.1% | | 16.8% | | 3.9% | | | | 12.9% | | (13.7)% |
| | | | | | | | | | | | |
Europe(1) | | 7.7% | | 6.7% | | 4.1% | | | | 2.5% | | 1.1% |
| | | | | | | | | | | | |
| Asia Pacific | | 2.7% | | 4.0% | | 3.1% | | | | 1.0% | | (1.3)% |
| | | | | | | | | | | | |
| Africa/Eurasia | | 1.2% | | 13.3% | | 7.6% | | | | 5.7% | | (12.1)% |
| | | | | | | | | | | | |
| Total CP Products | | 3.0% | | 8.1% | | 3.7% | | | | 4.4% | | (5.2)% |
| | | | | | | | | | | | |
| Hill’s | | 4.5% | | 4.9% | | 0.8% | | | | 4.1% | | (0.4)% |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Emerging Markets(2) | | 3.0% | | 12.2% | | 4.0% | | | | 8.2% | | (9.2)% |
| | | | | | | | | | | | |
| Developed Markets | | 3.5% | | 3.6% | | 2.3% | | | | 1.3% | | —% |
Notes: Table may not sum due to rounding.
(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.
(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Table 8 |
| Colgate-Palmolive Company |
|
| Non-GAAP Reconciliations |
|
| For the Three Months Ended December 31, 2024 and 2023 |
|
| (Dollars in Millions Except Per Share Amounts) (Unaudited) |
| | | | | | | | | | | | | |
| Gross Profit | | | | | | | | | 2024 | | 2023 | | |
| Gross profit, GAAP | | | | | | | | $ | 2,982 | | | $ | 2,950 | | | |
| 2022 Global Productivity Initiative | | | | | | | | 1 | | | — | | | |
| | | | | | | | | |
| Gross profit, non-GAAP | | | | | | | | $ | 2,983 | | | $ | 2,950 | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | | | | |
| Selling, General and Administrative Expenses | | | | | | 2024 | | 2023 | | |
| Selling, general and administrative expenses, GAAP | | | | | $ | 1,895 | | | $ | 1,803 | | | |
| 2022 Global Productivity Initiative | | | | | (1) | | | — | | | |
| Selling, general and administrative expenses, non-GAAP | | $ | 1,894 | | | $ | 1,803 | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Other (Income) Expense, Net | | | | | | | | 2024 | | 2023 | | |
| Other (income) expense, net, GAAP | | | | | $ | 23 | | | $ | 75 | | | |
| 2022 Global Productivity Initiative | | | | | (5) | | | (2) | | | |
| | | | | | | | | | | | |
| Other (income) expense, net, non-GAAP | | | | | $ | 18 | | | $ | 73 | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Operating Profit | | | | | | | | | 2024 | | 2023 | | % Change |
| Operating profit, GAAP | | | | | $ | 1,064 | | | $ | 1,072 | | | (1) | % |
| 2022 Global Productivity Initiative | | | | | | | | 7 | | | 2 | | | |
| | | | | | | | |
| | | | | | | | | | | | | |
| Operating profit, non-GAAP | | | | | $ | 1,071 | | | $ | 1,074 | | | — | % |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | Basis Point |
| Operating Profit Margin | | | | | | | | 2024 | | 2023 | | Change |
| Operating profit margin, GAAP | | | | | | | | 21.5 | % | | 21.7 | % | | (20) | |
| 2022 Global Productivity Initiative | | | | | | | | 0.2 | % | | — | % | | |
| | | | | | | | |
| | | | | | | | | | | | | |
| Operating profit margin, non-GAAP | | | | | | | | 21.7 | % | | 21.7 | % | | — | |
|
| | | | | | | | | | | | | |
| Non-Service Related Post Retirement Cost | | | | 2024 | | 2023 | | |
| Non-service related post retirement cost, GAAP | | | | $ | 20 | | | $ | 22 | | | |
| 2022 Global Productivity Initiative | | | | | | | | — | | | (1) | | | |
| Non-service post retirement cost, non-GAAP | | | | $ | 20 | | | $ | 21 | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
|
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| Table 8 |
| Continued |
| Colgate-Palmolive Company |
|
| Non-GAAP Reconciliations |
|
| For the Three Months Ended December 31, 2024 vs. 2023 |
|
| (Dollars in Millions Except Per Share Amounts) (Unaudited) |
| |
| |
| 2024 |
| Income Before
Income Taxes | | Provision For Income Taxes(1) | | Net Income
Including
Noncontrolling
Interests | | Net Income
Attributable To
Colgate-Palmolive
Company | | Effective Income Tax Rate(2) | | Diluted Earnings
Per Share |
| As Reported GAAP | $ | 994 | | | $ | 215 | | | $ | 779 | | | $ | 739 | | | 21.6 | % | | $ | 0.90 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| 2022 Global Productivity Initiative | 7 | | | 1 | | | 6 | | | 6 | | | — | % | | 0.01 | |
| | | | | | | | | | | |
| Non-GAAP | $ | 1,001 | | | $ | 216 | | | $ | 785 | | | $ | 745 | | | 21.6 | % | | $ | 0.91 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| 2023 |
| Income Before
Income Taxes | | Provision For Income Taxes(1) | | Net Income
Including
Noncontrolling
Interests | | Net Income
Attributable To
Colgate-Palmolive
Company | | Effective Income Tax Rate(2) | | Diluted Earnings
Per Share |
| As Reported GAAP | $ | 988 | | | $ | 228 | | | $ | 760 | | | $ | 718 | | | 23.1 | % | | $ | 0.87 | |
| | | | | | | | | | | |
| 2022 Global Productivity Initiative | 3 | | | 1 | | | 2 | | | 2 | | | — | % | | — | |
| | | | | | | | | | | |
| Non-GAAP | $ | 991 | | | $ | 229 | | | $ | 762 | | | $ | 720 | | | 23.1 | % | | $ | 0.87 | |
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Table 9 |
| Colgate-Palmolive Company |
| | |
| Non-GAAP Reconciliations |
| | |
| For the Twelve Months Ended December 31, 2024 vs. 2023 |
| | |
| (Dollars in Millions Except Per Share Amounts) (Unaudited) |
| | | | | | | | | | | | | | | |
| Gross Profit | | | | | | | | | | | 2024 | | 2023 | | |
| Gross profit, GAAP | | | | | | | $ | 12,161 | | | $ | 11,326 | | | |
| 2022 Global Productivity Initiative | | | | | | | 20 | | | 1 | | | |
| Gross profit, non-GAAP | | | | | | | $ | 12,181 | | | $ | 11,327 | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Basis Point |
| Gross Profit Margin | | | | | | | | | | 2024 | | 2023 | | Change |
| Gross profit margin, GAAP | | | | | | | | | | 60.5 | % | | 58.2 | % | | 230 | |
| 2022 Global Productivity Initiative | | | | | | | 0.1 | % | | — | % | | |
| Gross profit margin, non-GAAP | | | | | | | | | | 60.6 | % | | 58.2 | % | | 240 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| Selling, General and Administrative Expenses | | | | | | | | 2024 | | 2023 | | |
| Selling, general and administrative expenses, GAAP | | | | | | $ | 7,729 | | | $ | 7,151 | | | |
| 2022 Global Productivity Initiative | | | | | | | (6) | | | (2) | | | |
| Selling, general and administrative expenses, non-GAAP | | | | $ | 7,723 | | | $ | 7,149 | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Basis Point |
| Selling, General and Administrative Expenses as a Percentage of Net Sales | | | | 2024 | | 2023 | | Change |
| Selling, general and administrative expenses as a percentage of Net sales, GAAP | | | | 38.5 | % | | 36.8 | % | | 170 | |
| 2022 Global Productive Initiative | | | | | | | (0.1) | % | | (0.1) | % | | |
| Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | | | 38.4 | % | | 36.7 | % | | 170 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Other (Income) Expense, Net | | | | | | | | | | 2024 | | 2023 | | |
| Other (income) expense, net, GAAP | | | | | | | $ | 164 | | | $ | 191 | | | |
| 2022 Global Productivity Initiative | | | | | | | (59) | | | (24) | | | |
| Product recall costs | | | | | | | — | | | (25) | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| Other (income) expense, net, non-GAAP | | | | | | | $ | 105 | | | $ | 142 | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Operating Profit | | | | | | | | | | | 2024 | | 2023 | | % Change |
| Operating profit, GAAP | | | | | | | $ | 4,268 | | | $ | 3,984 | | | 7 | % |
| 2022 Global Productivity Initiative | | | | | | | 85 | | | 27 | | | |
| Product recall costs | | | | | | | — | | | 25 | | | |
| | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | |
| Operating profit, non-GAAP | | | | | | | $ | 4,353 | | | $ | 4,036 | | | 8 | % |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Basis Point |
| Operating Profit Margin | | | | | | | | | | 2024 | | 2023 | | Change |
| Operating profit margin, GAAP | | | | | | | 21.2 | % | | 20.5 | % | | 70 | |
| 2022 Global Productivity Initiative | | | | | | | 0.5 | % | | 0.1 | % | | |
| Product recall costs | | | | | | | — | % | | 0.1 | % | | |
| | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | |
| Operating profit margin, non-GAAP | | | | | | | | | | 21.7 | % | | 20.7 | % | | 100 | |
| | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Non-Service Related Post Retirement Cost | | | | | | 2024 | | 2023 | | |
| Non-service related post retirement cost, GAAP | | | | | | | $ | 87 | | | $ | 360 | | | |
| ERISA litigation matter | | | | | | | — | | | (267) | | | |
| 2022 Global Productivity Initiative | | | | | | | — | | | (5) | | | |
| Non-service post retirement cost, non-GAAP | | | | | | | $ | 87 | | | $ | 88 | | | |
| | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| Table 9 |
| Continued |
| Colgate-Palmolive Company |
| | |
| Non-GAAP Reconciliations |
| | |
| For the Twelve Months Ended December 31, 2024 vs. 2023 |
| | |
| (Dollars in Millions Except Per Share Amounts) (Unaudited) |
| | | |
| | | |
| 2024 |
| Income Before
Income Taxes | | Provision For Income Taxes(1) | | Net Income
Including
Noncontrolling
Interests | | Less: Income Attributable to Noncontrolling Interests | | Net Income
Attributable To
Colgate-Palmolive
Company | | Effective Income Tax Rate(2) | | Diluted Earnings
Per Share |
| As Reported GAAP | $ | 3,956 | | | $ | 907 | | | $ | 3,049 | | | $ | 160 | | | $ | 2,889 | | | 22.9 | % | | $ | 3.51 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| 2022 Global Productivity Initiative | 85 | | | 12 | | | 73 | | | — | | | 73 | | | (0.2) | % | | 0.09 | |
| | | | | | | | | | | | | |
| Non-GAAP | $ | 4,041 | | | $ | 919 | | | $ | 3,122 | | | $ | 160 | | | $ | 2,962 | | | 22.7 | % | | $ | 3.60 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| 2023 |
| Income Before
Income Taxes | | Provision For Income Taxes(1) | | Net Income
Including
Noncontrolling
Interests | | Less: Income Attributable to Noncontrolling Interests | | Net Income
Attributable To
Colgate-Palmolive
Company | | Effective Income Tax Rate(2) | | Diluted Earnings
Per Share |
| As Reported GAAP | $ | 3,392 | | | $ | 937 | | | $ | 2,455 | | | $ | 155 | | | $ | 2,300 | | | 27.6 | % | | $ | 2.77 | |
| ERISA litigation matter | 267 | | | 55 | | | 212 | | | — | | | 212 | | | (0.5) | % | | 0.26 | |
| Foreign tax matter | — | | | (126) | | | 126 | | | — | | | 126 | | | (3.4) | % | | 0.15 | |
| 2022 Global Productivity Initiative | 32 | | | 6 | | | 26 | | | 1 | | | 25 | | | (0.1) | % | | 0.03 | |
| Product recall costs | 25 | | | 6 | | | 19 | | | — | | | 19 | | | — | % | | 0.02 | |
| Non-GAAP | $ | 3,716 | | | $ | 878 | | | $ | 2,838 | | | $ | 156 | | | $ | 2,682 | | | 23.6 | % | | $ | 3.23 | |
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
v3.24.4
Cover
|
Jan. 31, 2025 |
| Cover [Abstract] |
|
| Document Type |
8-K
|
| Document Period End Date |
Jan. 31, 2025
|
| Entity Registrant Name |
COLGATE-PALMOLIVE COMPANY
|
| Entity Incorporation, State or Country Code |
DE
|
| Entity File Number |
1-644
|
| Entity Tax Identification Number |
13-1815595
|
| Entity Address, Address Line One |
300 Park Avenue,
|
| Entity Address, City or Town |
New York,
|
| Entity Address, State or Province |
NY
|
| Entity Address, Postal Zip Code |
10022
|
| City Area Code |
(212)
|
| Local Phone Number |
310-2000
|
| Written Communications |
false
|
| Soliciting Material |
false
|
| Pre-commencement Tender Offer |
false
|
| Pre-commencement Issuer Tender Offer |
false
|
| Document Information [Line Items] |
|
| Entity Central Index Key |
0000021665
|
| Amendment Flag |
false
|
| Entity Emerging Growth Company |
false
|
| Common Stock |
|
| Document Information [Line Items] |
|
| Title of 12(b) Security |
Common Stock, $1.00 par value
|
| Trading Symbol |
CL
|
| Security Exchange Name |
NYSE
|
| 0.500% Notes Due 2026 |
|
| Document Information [Line Items] |
|
| Title of 12(b) Security |
0.500% Notes due 2026
|
| Trading Symbol |
CL26
|
| Security Exchange Name |
NYSE
|
| 0.300% Notes Due 2029 |
|
| Document Information [Line Items] |
|
| Title of 12(b) Security |
0.300% Notes due 2029
|
| Trading Symbol |
CL29
|
| Security Exchange Name |
NYSE
|
| 1.375% Notes Due 2034 |
|
| Document Information [Line Items] |
|
| Title of 12(b) Security |
1.375% Notes due 2034
|
| Trading Symbol |
CL34
|
| Security Exchange Name |
NYSE
|
| 0.875% Notes due 2039 |
|
| Document Information [Line Items] |
|
| Title of 12(b) Security |
0.875% Notes due 2039
|
| Trading Symbol |
CL39
|
| Security Exchange Name |
NYSE
|
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCode for the postal or zip code
| Name: |
dei_EntityAddressPostalZipCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the state or province.
| Name: |
dei_EntityAddressStateOrProvince |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:stateOrProvinceItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTitle of a 12(b) registered security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
| Name: |
dei_Security12bTitle |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the Exchange on which a security is registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
| Name: |
dei_SecurityExchangeName |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarExchangeCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
| Name: |
dei_TradingSymbol |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:tradingSymbolItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=cl_A0.500NotesDue2026Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=cl_A0300NotesDue2029Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=cl_A1.375NotesDue2034Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
| X |
- Details
| Name: |
us-gaap_StatementClassOfStockAxis=cl_A0.875Notesdue2039Member |
| Namespace Prefix: |
|
| Data Type: |
na |
| Balance Type: |
|
| Period Type: |
|
|
Colgate Palmolive (NYSE:CL)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Colgate Palmolive (NYSE:CL)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
